Fussell Stephen R 4
Accession 0001179110-18-002536
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 7:23 PM ET
Size
49.7 KB
Accession
0001179110-18-002536
Insider Transaction Report
- Sale
Common shares without par value
2018-02-20$59.59/sh−100$5,960→ 279,397 total - Sale
Common shares without par value
2018-02-20$59.60/sh−22,500$1,341,000→ 256,897 total - Sale
Common shares without par value
2018-02-20$59.64/sh−1,700$101,388→ 253,097 total - Sale
Common shares without par value
2018-02-20$59.65/sh−600$35,787→ 252,497 total - Sale
Common shares without par value
2018-02-20$59.66/sh−2,985$178,100→ 233,302 total - Sale
Common shares without par value
2018-02-20$59.54/sh−226$13,456→ 281,751 total - Exercise/Conversion
Common shares without par value
2018-02-20$38.40/sh+104,642$4,018,253→ 289,526 total - Sale
Common shares without par value
2018-02-20$59.48/sh−300$17,844→ 288,126 total - Sale
Common shares without par value
2018-02-20$59.50/sh−1,200$71,400→ 285,066 total - Sale
Common shares without par value
2018-02-20$59.52/sh−200$11,903→ 283,694 total - Sale
Common shares without par value
2018-02-20$59.52/sh−728$43,331→ 282,966 total - Sale
Common shares without par value
2018-02-20$59.59/sh−500$29,793→ 279,997 total - Sale
Common shares without par value
2018-02-20$59.63/sh−500$29,818→ 254,797 total - Sale
Common shares without par value
2018-02-20$59.65/sh−4,794$285,962→ 247,703 total - Sale
Common shares without par value
2018-02-20$59.66/sh−3,200$190,896→ 244,503 total - Sale
Common shares without par value
2018-02-20$59.66/sh−8,206$489,570→ 236,287 total - Sale
Common shares without par value
2018-02-20$59.67/sh−77$4,594→ 233,225 total - Exercise/Conversion
Option (right to buy)
2018-02-20−104,642→ 104,642 totalExercise: $38.40From: 2018-02-19Exp: 2026-02-18→ Common shares (104,642 underlying) - Sale
Common shares without par value
2018-02-20$59.47/sh−1,100$65,417→ 288,426 total - Sale
Common shares without par value
2018-02-20$59.56/sh−180$10,721→ 280,997 total - Award
Common shares without par value
2018-02-16+44,909→ 184,884 total - Sale
Common shares without par value
2018-02-20$59.49/sh−1,419$84,416→ 286,707 total - Sale
Common shares without par value
2018-02-20$59.49/sh−441$26,237→ 286,266 total - Sale
Common shares without par value
2018-02-20$59.51/sh−1,172$69,746→ 283,894 total - Sale
Common shares without par value
2018-02-20$59.53/sh−989$58,875→ 281,977 total - Sale
Common shares without par value
2018-02-20$59.55/sh−574$34,179→ 281,177 total - Sale
Common shares without par value
2018-02-20$59.58/sh−500$29,790→ 280,497 total - Sale
Common shares without par value
2018-02-20$59.67/sh−100$5,967→ 233,125 total - Sale
Common shares without par value
2018-02-20$59.59/sh−500$29,795→ 279,497 total - Sale
Common shares without par value
2018-02-20$59.63/sh−1,600$95,408→ 255,297 total - Sale
Common shares without par value
2018-02-20$59.66/sh−10$597→ 244,493 total - Award
Option (right to buy)
2018-02-16+246,963→ 246,963 totalExercise: $59.94From: 2019-02-16Exp: 2028-02-15→ Common shares (246,963 underlying)
Footnotes (3)
- [F1]These shares represent performance vested restricted stock awards under the Abbott Laboratories 2017 Incentive Stock Program. The awards have a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.
- [F2]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 82,321 on 02/16/2019, 82,321 on 02/16/2020, and 82,321 on 02/16/2021.
- [F3]Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
Documents
Issuer
ABBOTT LABORATORIES
CIK 0000001800
Related Parties
1- filerCIK 0001327700
Filing Metadata
- Form type
- 4
- Filed
- Feb 20, 7:00 PM ET
- Accepted
- Feb 21, 7:23 PM ET
- Size
- 49.7 KB